Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...
Morning Overview on MSN
A single injection just slashed dangerous cholesterol by more than half for a full year — a gene-silencing shot aimed at the root of heart disease
Twice a year, a nurse slides a small needle under the skin of your upper arm. Thirty seconds later, you are done. No daily ...
A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections. The drug, called enlicitide, slashes levels ...
High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...
In late-stage studies, Merck & Co.’s PCSK9-targeted pill achieved low-density lipoprotein cholesterol (LDL-C) reductions similar to those observed with existing injectables. The results from two phase ...
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...
A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered "bad" LDL cholesterol by more than half in a global study ...
Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results